SK-MEL-37 (Q54954130)

31 January 2023

1 reference

AU cell-surface antigen of human malignant melanoma: solubilization and partial characterization

31 January 2023

1 reference

31 January 2023

Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens

1 reference

31 January 2023

Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells

1 reference

31 January 2023

Aberrant Elevation of Tyrosine-specific Phosphorylation in Human Gastric Cancer Cells

1 reference

31 January 2023

Cytolytic T-cell clones against an autologous human melanoma: specificity study and definition of three antigens by immunoselection

1 reference

31 January 2023

Loss of polymorphic restriction fragments in malignant melanoma: implications for tumor heterogeneity

1 reference

31 January 2023

A molecular mechanism of complement resistance of human melanoma cells

1 reference

31 January 2023

Human tumor lines for cancer research.

1 reference

31 January 2023

A pigmentation-associated, differentiation antigen of human melanoma defined by a precipitating antibody in human serum.

1 reference

31 January 2023

Cell surface antigens of human ovarian and endometrial carcinoma defined by mouse monoclonal antibodies

1 reference

31 January 2023

Detection of cell surface and intracellular antigens by human monoclonal antibodies. Hybrid cell lines derived from lymphocytes of patients with malignant melanoma

1 reference

31 January 2023

Serological survey of normal humans for natural antibody to cell surface antigens of melanoma

1 reference

31 January 2023

Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets

1 reference

31 January 2023

Identification of PTEN/MMAC1 alterations in uncultured melanomas and melanoma cell lines

1 reference

31 January 2023

Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous melanoma cell lines.

1 reference

31 January 2023

Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma

1 reference

31 January 2023

Concurrent loss of the PTEN and RB1 tumor suppressors attenuates RAF dependence in melanomas harboring (V600E)BRAF

1 reference

31 January 2023

Loss of NF1 in cutaneous melanoma is associated with RAS activation and MEK dependence

1 reference

31 January 2023

HLA-A, B, C and DR alloantigen expression on forty-six cultured human tumor cell lines

1 reference

31 January 2023

established from medical condition

skin amelanotic melanoma

1 reference

31 January 2023

derived from organism type

1 reference

http://purl.obolibrary.org/obo/BTO_0002967

31 January 2023

1 reference

31 January 2023

Identifiers

1 reference

31 January 2023